These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17847052)

  • 41. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
    Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
    Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Abraham WT; Fonarow GC; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Am Coll Cardiol; 2008 Jul; 52(5):347-56. PubMed ID: 18652942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of conditional moment tests to model checking for generalized linear models.
    Pan W
    Biostatistics; 2002 Jun; 3(2):267-76. PubMed ID: 12933617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Instrumental variables: application and limitations.
    Martens EP; Pestman WR; de Boer A; Belitser SV; Klungel OH
    Epidemiology; 2006 May; 17(3):260-7. PubMed ID: 16617274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chronic heart failure and sudden death: the message of CIBIS-III].
    Dequarti MC; Poggio L; Vanoli E
    Recenti Prog Med; 2007 Dec; 98(12):638-45. PubMed ID: 18369041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Replication of the Scandinavian Simvastatin Survival Study using a primary care medical record database prompted exploration of a new method to address unmeasured confounding.
    Weiner MG; Xie D; Tannen RL
    Pharmacoepidemiol Drug Saf; 2008 Jul; 17(7):661-70. PubMed ID: 18327857
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systematic differences in treatment effect estimates between propensity score methods and logistic regression.
    Martens EP; Pestman WR; de Boer A; Belitser SV; Klungel OH
    Int J Epidemiol; 2008 Oct; 37(5):1142-7. PubMed ID: 18453634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers.
    Flannery G; Gehrig-Mills R; Billah B; Krum H
    Am J Cardiol; 2008 Mar; 101(6):865-9. PubMed ID: 18328855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How to deal with continuous and dichotomic outcomes in epidemiological research: linear and logistic regression analyses.
    Tripepi G; Jager KJ; Stel VS; Dekker FW; Zoccali C
    Nephron Clin Pract; 2011; 118(4):c399-406. PubMed ID: 21346375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Do cardioselective beta-adrenoceptor antagonists reduce mortality in diabetic patients with congestive heart failure?
    Subramanian U; Kamalesh M; Temkit M; Eckert GJ; Sawada S
    Am J Cardiovasc Drugs; 2009; 9(4):231-40. PubMed ID: 19655818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sample size calculations for evaluating mediation.
    Vittinghoff E; Sen S; McCulloch CE
    Stat Med; 2009 Feb; 28(4):541-57. PubMed ID: 19065627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quality of life and prognosis in heart failure: results of the Beta-Blocker Evaluation of Survival Trial (BEST).
    Tate CW; Robertson AD; Zolty R; Shakar SF; Lindenfeld J; Wolfel EE; Bristow MR; Lowes BD
    J Card Fail; 2007 Nov; 13(9):732-7. PubMed ID: 17996821
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantifying the potential role of unmeasured confounders: the example of influenza vaccination.
    Groenwold RH; Hoes AW; Nichol KL; Hak E
    Int J Epidemiol; 2008 Dec; 37(6):1422-9. PubMed ID: 18725358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Strategies for analyzing multilevel cluster-randomized studies with binary outcomes collected at varying intervals of time.
    Olsen MK; DeLong ER; Oddone EZ; Bosworth HB
    Stat Med; 2008 Dec; 27(29):6055-71. PubMed ID: 18825655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The missing cause approach to unmeasured confounding in pharmacoepidemiology.
    Abrahamowicz M; Bjerre LM; Beauchamp ME; LeLorier J; Burne R
    Stat Med; 2016 Mar; 35(7):1001-16. PubMed ID: 26932124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Categorical data analysis in primary care research: log-linear models.
    Crabtree BF; Gelfand AE; Miller WL; Zyzanski S; O'Connor PJ; Winsemius D
    Fam Med; 1992 Feb; 24(2):145-51. PubMed ID: 1537448
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A simulation-based comparison of techniques to correct for measurement error in matched case-control studies.
    Guolo A; Brazzale AR
    Stat Med; 2008 Aug; 27(19):3755-75. PubMed ID: 18407572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.